OncLive’s State of the Science Summit Will Highlight Ovarian Cancer Treatments

OncLive’s State of the Science Summit Will Highlight Ovarian Cancer Treatments
OncLive’s latest State of the Science Summit will feature discussions of novel treatments for ovarian cancer and soft tissue sarcoma (STS), with presenters from the Dana-Farber Cancer Institute. To be held Dec. 11 in Boston, Massachusetts at The Colonnade Boston Hotel, the interactive and educational meeting will be chaired by Joyce Fu Liu, the institute’s director of clinical research, division of gynecologic oncology. She’s also an assistant professor of medicine at Harvard Medical School. Go here to register for the free event, or contact Kayla Collins at [email protected] A new podcast, OncLive On Air, will feature interviews with faculty conducted at this and other summits. The Boston meeting targets community oncologists interested in the treatment of ovarian cancer and STS patients. Academic fellows, nurse practitioners, researchers, and other healthcare professionals are also invited. In addition to delving into topics facing ovarian cancer specialists and related professionals, presenters will discuss issues such as surgical options in newly diagnosed ovarian cancer, newly diagnosed advanced ovarian cancer, genetic testing in ovarian cancer, systemic treatment of STS or uterine leiomyosarcoma, treatment of recurrent ovarian cancer,
Subscribe or to access all post and page content.